Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 397-401

  Waterhouse, M ^a   Duque Afonso, J ^a   Wasch R ^a   Bertz, H ^a   Finke, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; GENETIC POLYMORPHISM; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE;

3' UNTRANSLATED REGIONS; ADULT; AGED; ALLELES; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-G ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; POLYMORPHISM, GENETIC; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84873303198     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.05.073     Document Type: Article

References (14)

1. B. Deschler, K. Binek, G. Ihorst Prognostic factor and quality of life analysis in 160 patients aged > or = 60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 16 2010 967
2. Z. Lim, R. Brand, R. Martino Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodisplastic syndromes or secondary acute myeloid leukemia J Clin Oncol 28 2010 405
3. R. Marks, K. Potthoff, J. Hahn Reduced-toxicity conditioning with fludarabine, BCNU and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies Blood 112 2008 415
4. T.A. Gooley, J.W. Chien, S.A. Pergam Reduced mortality after allogeneic hematopoietic-cell transplantation N Engl J Med 363 2010 2091
5. B. Riteau, C. Menier, I. Khalil-Daher HLA-G inhibits the allogeneic proliferative response J Reprod Immunol 43 1999 203
6. N. Lila, N. Rouas-Freiss, J. Dausset Soluble HLA-G protein secreted by allo-specific CD4+T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism Proc Natl Acad Sci U S A 98 2001 12150
7. S. Le Rond, J. Le Moult, C. Creput Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients Eur J Immunol 34 2004 649
8. A. Le Maux, G. Noël, B. Birebent Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells Clin Exp Immunol 152 2008 50
9. X.Y. Chen, W.H. Yan, A. Lin The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma Tissue Antigens 72 2008 335
10. G. La Nasa, R. Littera, F. Locatelli The human leucocyte antigen-G 14 basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia Br J Haematol 139 2007 284
11. P. Chiusolo, S. Bellesi, N. Piccirillo The role of HLA-G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis Bone Marrow Transplant 47 2011 120
12. M.E. Flowers, Y. Inamoto, P.A. Carpenter Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria Blood 117 2011 3214
13. G.A. Harrison, K.E. Humphrey, I.B. Jakobsen A 14 bp deletion polymorphism in the HLA-G gene Hum Mol Genet 2 1993 2200
14. V. Rebmann, J. Lemaoult, N. Rouas-Freiss Report of the Wet Workshop for Quantification of soluble HLA-G in Essen 2004 Hum Immunol 66 2005 853